GILD241122P103000
- 0.00
- 0.000.00%
Gilead Sciences Newsroom
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Overnight news: US stocks closed higher, Dow hit a new high, escalation of Russia-Ukraine conflict boosted oil prices, Tesla is preparing for the Cybertruck to enter the China market
For more global financial news, please visit the 7×24 hours real-time financial news market close: The Dow Jones closed over 400 points higher, setting a new historical high. All three major indices recorded gains this week. On November 22, the top 20 transactions in the US stock market: It is reported that Tesla is preparing for the Cybertruck's entry into the china market. On Friday, china concept stocks showed mixed results, with WeRide rising 9.2% and pdd holdings falling 3.9%. The crude oil in the usa rose 6.5% this week, while the escalation of the Russia-Ukraine conflict pushed oil prices higher. Spot gold rose 5.7% in five days, regaining the $2,700 mark. European stocks all closed higher, with Germany's DAX 30 index up 0.84%. Macro.
The Children's Inn at NIH Announces $1 Million Grant From Gilead Sciences, Inc.
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Gilead Sciences Price Target Raised to $96.00/Share From $70.00 by UBS
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Optimism Over Global Healthcare Sector Rises: Jefferies
UBS Initiates Gilead Sciences(GILD.US) With Hold Rating, Announces Target Price $96
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Gilead Sciences Is Maintained at Outperform by Mizuho
Mizuho Securities Maintains Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $100
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)
Market Falls on Retail Results, Bitcoin Swells, All Eyes on Nvidia | Live Stock
Mizuho Securities Adjusts Price Target on Gilead Sciences to $100 From $90
RBC Capital raised the target price of gilead sciences to $84.
RBC Capital: Raised gilead sciences' target price from $81 to $84, maintaining a "synchronized with the market" rating. (Gelonghui)
Unusual Options Activity: JNPR, CE and Others Attract Market Bets, JNPR V/OI Ratio Reaches 909.1
Bitcoin Climbs to Fresh High, Market Shifts into Climb | Wall Street Today